Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience | Lepik | Oncohematology

Oncohematology
Onkogematologiâ

ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)

eng | рус

Preview

Oncohematology

Advanced search

Archives

Download this PDF file

For citations:

Lepik K.V., Mikhailova N.V., Kondakova E.V., Tsvetkova L.A., Zalyalov Yu.R., Borzenkova E.S., Moiseev I.S., Baykov V.V., Afanasyev B.A. Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience. Oncohematology. 2018;13(4):17-26. (In Russ.) https://doi.org/10.17650/1818-8346-2019-13-4-17-26

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Pervin A. Zeynalova

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Notifications

About the Authors

K. V. Lepik
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

N. V. Mikhailova
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

E. V. Kondakova
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

L. A. Tsvetkova
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

Yu. R. Zalyalov
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

E. S. Borzenkova
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

I. S. Moiseev
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

V. V. Baykov
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg

B. A. Afanasyev
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

6–8 L’va Tolstogo St., 197022 Saint Petersburg